A similar in silico approach to that implemented here has already been recently exploited in our laboratory to study cancer-related mutations affecting the EphA2-Sam/Ship2-Sam complex [58], representing another protein–protein interaction mediated by EphA2-Sam that is mainly linked to pro-oncogenic outcomes [20]. Here, EPHA2 is linked to cancer.